D. Ballantyne

发表

Effect of exercise training on the total ischaemic burden: an assessment by 24 hour ambulatory electrocardiographic monitoring

I. Todd, D. Ballantyne, 1992, British heart journal.

Sex differences in autoregulation of juxtamedullary glomerular blood flow in hydronephrotic rats.

D. Ballantyne, M. Steinhausen, M. Fretschner, 1990, The American journal of physiology.

Resistin is a predictor of asthma risk and resistin:adiponectin ratio is a negative predictor of lung function in asthma

L. Wood, P. Gibson, H. Scott, 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Left ventricular function and beta-blockers: Does intrinsic sympathomimetic activity have any influence during chronic therapy?

D. Ballantyne, M. Cooke, R. Northcote, 1988, Cardiovascular Drugs and Therapy.

Electrocardiographic events before, during and after acute myocardial infarction in 2 ambulant subjects.

D. Ballantyne, R. Northcote, 1983, The American journal of cardiology.

Metabolism of very low density lipoprotein of Sf 100-400 in type V hyperlipoproteinaemia.

A. Olsson, D. Ballantyne, S. Rossner, 2009, Acta medica Scandinavica.

The composition of low-density lipoprotein and very-low-density lipoprotein subfractions in primary hypothyroidism and the effect of hormone-replacement therapy.

M. Caslake, D. Ballantyne, A. Epenetos, 1979, Clinical science.

Plasma protein concentrations in hypertriglyceridaemic subjects. Effect of clofibrate and comparison with normal subjects.

D. Ballantyne, A. Epenetos, F. Ballantyne, 1978, Clinica chimica acta; international journal of clinical chemistry.

Acute effect of dietary therapy of type IV hyperlipoproteinaemia on the serum and lipoprotein concentrations and relative composition.

A. Olsson, D. Ballantyne, L. Carlson, 1978, Atherosclerosis.

On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.

D. Ballantyne, L. Carlson, G. Olsson, 1977, Atherosclerosis.

Exclusion of pre-beta lipoproteins from agarose gel electrophoresis in the presence of chylomicrons.

D. Ballantyne, L. Carlson, 1976, Scandinavian journal of clinical and laboratory investigation.

Changing relative proportions of apolipoproteins CII and CIII of very low density lipoproteins in hypertriglyceridaemia.

D. Ballantyne, L. Carlson, 1976, Atherosclerosis.

Relationship between lipid composition of very low density lipoprotein and electrophoretic mobility in agarose gel.

D. Ballantyne, 1976, Scandinavian journal of clinical and laboratory investigation.

Hyperlipoproteinaemia and peripheral vascular disease.

T. Lawrie, D. Ballantyne, 1973, Clinica chimica acta; international journal of clinical chemistry.

Electrocardiographic findings in male veteran endurance athletes.

D. Ballantyne, R. Northcote, G. Canning, 1989, British heart journal.

The effect of sotalol on plasma lipoproteins and apolipoproteins.

C. Packard, D. Ballantyne, R. Northcote, 1986, Clinica chimica acta; international journal of clinical chemistry.

Thiazides, beta blockers and lipoproteins.

D. Ballantyne, F. Ballantyne, 1983, Postgraduate medical journal.

Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins.

D. Ballantyne, F. Ballantyne, McMurdo, 1981, Atherosclerosis.

Diabetic Cardiomyopathy: The Available Evidence

D. Ballantyne, C. Kesson, R. Northcote, 1985, Scottish medical journal.

The Effect of Moderate Physical Exercise on the Plasma Lipoprotein Subfractions of Male Survivors of Myocardial Infarction

D. Ballantyne, H. Simpson, F. Ballantyne, 1982, Circulation.

High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects.

D. Ballantyne, H. Simpson, F. Ballantyne, 1982, Metabolism: clinical and experimental.

Cardiac adaptations to training: relevance to angina pectoris.

I. Todd, D. Ballantyne, 1986, International journal of cardiology.

Coronary care in the elderly.

B. O. Williams, D. Ballantyne, J. Macdonald, 1983, Age and ageing.

Relationship of plasma lipids and lipoprotein concentration to cerebral atherosclerosis and electrocardiographic findings.

K. Grossart, T. Lawrie, D. Ballantyne, 1974, Journal of the neurological sciences.

Doppler echocardiography in elderly patients with ejection systolic murmurs.

G. McKillop, D. Ballantyne, D. Stewart, 1991, Postgraduate medical journal.

A prospective randomized trial of tocainide in patients following myocardial infarction.

P. Macfarlane, W. Hillis, A. Rae, 1980, American heart journal.

SCREENING EXPERIENCE AND BASE-LINE CHARACTERISTICS IN THE WEST OF SCOTLAND CORONARY PREVENTION STUDY

P. Macfarlane, J. Norrie, C. Packard, 1995 .

Lipoprotein concentrations in untreated adult onset diabetes mellitus and the relationship of the fasting plasma triglyceride concentration to insulin secretion.

H. G. Morgan, T. Lawrie, D. Ballantyne, 1977, Clinica chimica acta; international journal of clinical chemistry.

Increased left ventricular mass in a bodybuilder using anabolic steroids.

G. McKillop, I. Todd, D. Ballantyne, 1986, British journal of sports medicine.

Antianginal efficacy of exercise training: a comparison with beta blockade.

I. Todd, D. Ballantyne, 1990, British heart journal.

REVIEWARTICLE Thiazides, betablockers andlipoproteins

D. Ballantyne, 1983 .

Cardiovascular implications of strenuous exercise.

D. Ballantyne, R. Northcote, 1985, International journal of cardiology.

Sudden cardiac death in sport.

D. Ballantyne, R. Northcote, 1983, British medical journal.

Sudden Death and Sport

D. Ballantyne, R. Northcote, 1984, The Lancet.

SUDDEN DEATH IN A MARATHON RUNNER

D. Ballantyne, R. Northcote, 1983, The Lancet.

Effects of daily high-intensity exercise on myocardial perfusion in angina pectoris.

M. Bradnam, I. Todd, D. Ballantyne, 1991, The American journal of cardiology.

Lipoprotein analysis in bodybuilders.

G. McKillop, D. Ballantyne, 1987, International journal of cardiology.

Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.

H. G. Morgan, C. Packard, J. Shepherd, 1984, The Journal of clinical investigation.

Limb blood flow in treated hyperlipoproteinaemic patients with peripheral vascular disease. A preliminary report.

T. Lawrie, D. Ballantyne, J. Pollock, 1977, Atherosclerosis.

Study of the pedigree of a patient with type III hyperlipoproteinaemia and sinking prebeta lipoprotein

H. G. Morgan, T. Lawrie, D. Ballantyne, 1973, Journal of clinical pathology.

Compliance and adverse event withdrawal: their impact on the West of Scotland Coronary Prevention Study.

P. Macfarlane, J. Kennedy, J. Norrie, 1997, European heart journal.

Influence of intrinsic sympathomimetic activity on respiratory function during chronic beta blockade: comparison of propranolol and pindolol.

D. Ballantyne, R. Northcote, 1986, British medical journal.

Relationship of plasma uric acid to plasma lipids and lipoproteins in subjects with peripheral vascular disease.

T. Lawrie, D. Ballantyne, E. Strevens, 1976, Clinica chimica acta; international journal of clinical chemistry.

Abolition of exercise induced ST depression after exercise training and its recurrence after beta blockade.

I. Todd, D. Ballantyne, J. McGuinness, 1988, British heart journal.

Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia.

D. Ballantyne, D. Bedford, F. Ballantyne, 1978, Clinica chimica acta; international journal of clinical chemistry.

Prevalence of lipoprotein abnormalities in patients with peripheral vascular disease.

H. G. Morgan, T. Lawrie, D. Ballantyne, 1973, Annales de biologie clinique.

Beta Blockers and Lipoproteins: A Review of Current Knowledge

I. Todd, D. Ballantyne, R. Northcote, 1986, Scottish medical journal.

The composition of low (LDL) and very low (VLDL) density lipoprotein subfractions in type III hyperlipoproteinaemia: comparison with normal subjects.

D. Ballantyne, D. Bedford, F. Ballantyne, 1977, Clinica chimica acta; international journal of clinical chemistry.

Electrophoretic mobility in agarose of very low density lipoprotein subfractions in type III hyperlipoproteinaemia.

C. Packard, D. Ballantyne, D. Bedford, 1977, Clinica chimica acta; international journal of clinical chemistry.

Reducing the prevalence of exercise related cardiac death.

D. Ballantyne, R. Northcote, 1984, British journal of sports medicine.

Physical Activity and Coronary Heart Disease

D. Ballantyne, R. Clark, Clark Rs, 1981, Scottish medical journal.

Acute metabolic effects of exercise in bodybuilders using anabolic steroids.

G. McKillop, D. Ballantyne, F. Ballantyne, 1989, British journal of sports medicine.

The effects of body building and anabolic steroids on left ventricular structure and function

G. McKillop, I. Todd, D. Ballantyne, 1989 .

The short-term metabolic effects of strenuous exercise in bodybuilders.

G. McKillop, G. Fell, D. Ballantyne, 1988, British journal of sports medicine.

The Inheritance of Mild type II Hyperlpoproteinaemia

T. Lawrie, D. Ballantyne, 1975, Scottish medical journal.

METABOLIC DEFECT IN TYPE-III HYPERLIPOPROTEINÆMIA

D. Ballantyne, F. Ballantyne, P. Stromberg, 1977, The Lancet.

Beta-Adrenoceptor Blockade and Intrinsic Sympathomimetic Activity — Relevance in the Treatment of Ischaemic Heart Disease

D. Ballantyne, R. Northcote, R.J. Northcote, 1985, Scottish medical journal.

Different responses of cortical and juxtamedullary arterioles to norepinephrine and angiotensin II.

D. Ballantyne, M. Steinhausen, M. Fretschner, 1990, Kidney international. Supplement.

West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials

P. Macfarlane, J. Kennedy, J. Norrie, 1996 .

Delay in diagnosis of right atrial myxoma

D. Ballantyne, B. Sethia, R. Northcote, 1985, Clinical cardiology.

Does training post-infarct patients reduce the risk of reinfarction?

D. Ballantyne, 1983, International journal of cardiology.

Continuous 24-hour electrocardiography in thyrotoxicosis before and after treatment.

P. Macfarlane, D. Ballantyne, C. Kesson, 1986, American heart journal.

Influence of power and aerobic exercise training on haemostatic factors after coronary artery surgery

D. Ballantyne, D. Wosornu, P. Tansey, 1992, British heart journal.

Ambulatory electrocardiography in squash players.

P. Macfarlane, D. Ballantyne, R. Northcote, 1983, British heart journal.

Systolic murmurs in pregnancy: Value of echocardiographic assessment

D. Ballantyne, P. Knight, R. Northcote, 1985, Clinical cardiology.

Sudden death and vigorous exercise--a study of 60 deaths associated with squash.

R J Northcote, D Ballantyne, D. Ballantyne, 1986, British heart journal.

SUDDEN DEATH IN SQUASH PLAYERS

Anthony B. Evans, D. Ballantyne, RobinJ. Northcote, 1984, The Lancet.

Staffing in cardiology in the United Kingdom 1988. Fifth biennial survey.

E. Sowton, D. Chamberlain, D. Ballantyne, 1989, British heart journal.

Lipoprotein profiles of elite veteran endurance athletes.

I. Todd, D. Ballantyne, R. Northcote, 1988, The American journal of cardiology.

Response of plasma lipoproteins and acute phase proteins to myocardial infarction.

D. Ballantyne, F. Ballantyne, B. Morrison, 1979, Clinica chimica acta; international journal of clinical chemistry.

A comparison of the effects of strength and aerobic exercise training on exercise capacity and lipids after coronary artery bypass surgery.

D. Ballantyne, D. Bedford, D. Wosornu, 1996, European heart journal.

Effects of Chenodeoxycholic Acid (CD) Treatment on Endogenous Plasma Triglyceride (TG) Transport in Hyperlipoproteinemia (HLP)

T. M. Hayes, M. Freeman, S. Fujii, 1978 .

Type 3 hyperlipoproteinaemia and sinking prebeta lipoprotein.

D. Ballantyne, J. Jubb, 1973, Journal of Clinical Pathology.

CORONARY CARE IN THE ELDERLY

B. O. Williams, D. Ballantyne, J. Macdonald, 1983 .

The influence of beta-adrenoceptor blockers with and without intrinsic sympathomimetic activity on heart rate, arrhythmias and ST-T segments, using ambulatory electrocardiography.

D. Ballantyne, R. Northcote, 1988, British journal of clinical pharmacology.